Contrasting Oscar Health (NYSE:OSCR) and bioAffinity Technologies (NASDAQ:BIAF)

Oscar Health (NYSE:OSCR – Get Free Report) and bioAffinity Technologies (NASDAQ:BIAF – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.

Profitability

This table compares Oscar Health and bioAffinity Technologies’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Oscar Health 4.90% 49.39% 9.29%
bioAffinity Technologies -278.90% -293.44% -160.36%

Earnings & Valuation

This table compares Oscar Health and bioAffinity Technologies”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Oscar Health $17.47 billion 0.56 -$443.15 million $2.42 12.93
bioAffinity Technologies $6.16 million 0.59 -$14.91 million ($44.27) -0.05

bioAffinity Technologies has lower revenue, but higher earnings than Oscar Health. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Oscar Health has a beta of 2.56, indicating that its share price is 156% more volatile than the S&P 500. Comparatively, bioAffinity Technologies has a beta of -1.03, indicating that its share price is 203% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and target prices for Oscar Health and bioAffinity Technologies, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health 1 7 4 1 2.38
bioAffinity Technologies 1 0 0 0 1.00

Oscar Health presently has a consensus price target of $34.60, indicating a potential upside of 10.56%. Given Oscar Health’s stronger consensus rating and higher probable upside, equities analysts plainly believe Oscar Health is more favorable than bioAffinity Technologies.

Institutional & Insider Ownership

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 1.6% of bioAffinity Technologies shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by insiders. Comparatively, 2.4% of bioAffinity Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Oscar Health beats bioAffinity Technologies on 13 of the 15 factors compared between the two stocks.

About Oscar Health

(Get Free Report)

Oscar Health is a U.S. health insurance company that uses technology and digital tools to connect members with health coverage and care. Founded in 2012, the company initially focused on individual health plans and has expanded its offerings to include coverage for small businesses. Oscar’s products include individual and family plans, generally offered through the Affordable Care Act marketplaces, as well as small-group health insurance. Its services include a mobile app and online tools for managing benefits, finding care, and communicating with care teams.

About bioAffinity Technologies

(Get Free Report)

bioAffinity Technologies is a biotechnology company focused on developing diagnostic tests for lung disease, including lung cancer. Its work centers on applying flow cytometry and other technologies to analyze biological samples and support earlier disease detection. The company’s lead product, CyPath Lung, is a laboratory-developed test that analyzes sputum samples using proprietary technology. It is intended to help assess lung cancer risk in patients with suspicious pulmonary nodules and is offered through the company’s clinical laboratory subsidiary, Precision Pathology Services.

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.